Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:

Bristol-Myers Squibb Newsletter

SystImmune & Bristol Myers Squibb announce first global phase I results of iza─bren, an EGFR x HER3 bispecific ADC, in patients with advanced solid tumours at ESMO 2025 20 Oct 2025 08:32 GMT
… stage biotechnology company, and Bristol Myers Squibb announced the oral presentation … , oncology and cell therapy, Bristol Myers Squibb. "The encouraging activity … cutting-edge biologics development. Bristol Myers Squibb is a global biopharmaceutical …
Bristol Myers Squibb, SystImmune report data from lung cancer trial 17 Oct 2025 15:35 GMT
Bristol Myers Squibb (NYSE:BMY) and SystImmune reported … developed collaboratively by SystImmune and Bristol Myers
SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025 17 Oct 2025 14:49 GMT
… -stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today … biologics development. About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical … ;systimmune.com/. Bristol Myers Squibb Cautionary Statement Regarding Forward- …
FG, global partners launch innovative cancer medicine study 22 Oct 2025 09:47 GMT
… Parker Institute for Cancer Immunotherapy, Bristol Myers Squibb, and Roche. Over the …
<![CDATA[After Narrow Miss in Phase 3 Study, IO Biotech Ponders Next Steps for Immune-modulatory, Off-the-Shelf Cancer Vaccine]]> 22 Oct 2025 10:13 GMT
… used with nivolumab (Opdivo; Bristol Myers Squibb), met its primary end point …
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V. 22 Oct 2025 10:45 GMT
… and specialized pharmaceutical collaborators, including Bristol Myers Squibb, Duality Biologics, Fosun Pharma …
BioNTech beginnt öffentliches Umtauschangebot für alle ausstehenden Aktien von CureVac N.V. 22 Oct 2025 10:45 GMT
… aus der pharmazeutischen Industrie, darunter Bristol Myers Squibb, Duality Biologics, Fosun Pharma …
Is $1B in recent deals a reason for optimism in Mass. biotech? 22 Oct 2025 03:52 GMT
… this month, pharma giant Bristol Myers Squibb paid $1.5 billion for …
Galapagos to Wind Down Cell Therapy Business After Search for a Buyer Comes Up Empty 22 Oct 2025 01:16 GMT
… dealmaking. Earlier this month, Bristol Myers Squibb reached a $1.5 billion …
T-Dxd may be new standard for high-risk breast cancer 21 Oct 2025 22:45 GMT
… from or travel from AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS